Serum levels of COX-2, AQP1, and G17 in the LC group were higher than those in the control group (P<0.05), while serum PGI levels were lower in the LC group than those in the control group (P<0.05) (Table-II). The gene discussed is PTGS2; the disease is laryngotracheoesophageal cleft.